Point72 Asset Management, L.P. - 31 Dec 2024 SCHEDULE 13G/A Report for Inhibikase Therapeutics, Inc. Common Stock, par value $0.001 per share (IKT)

Filing Manager
Point72 Asset Management, L.P.
Reporting Manager
Point72 Asset Management, L.P.
Security
Inhibikase Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
IKT
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 16:08:35 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Point72 Asset Management, L.P. 0% 0 0 0 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Point72 Capital Advisors, Inc. 0% 0 0 0 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Steven A. Cohen 0% 0 0 0 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person